Focusing forward: Skills you must build today to develop the cell and gene therapies of tomorrow
The CGT market is poised to undergo significant growth over the next 2-5 years. BIS Research recently reported that “the global gene therapy market was valued at $1.07 billion in 2018 and is estimated to grow over $8.95 billion by 2025. Over the next 10 years, some experts predict more than one-third of therapies will be cell- and gene- based. As a relatively young field, employers already struggle to find sufficient qualified talent with the relevant therapeutic, manufacturing and regulatory expertise. Unless drastic and coordinated steps are taken, this will become a critical roadblock in bringing innovative new therapies to market. This session explores both the origins of this problem as well as potential action steps that can be taken to address this issue.
We’ve got work figured out.
In calm or chaos, you can count on us for guidance. Because we’ve been around, and we’ll be here for you. We know a thing or two about the future of work—and we can’t wait to help you discover what’s next.
Contact us at 800.Kelly.01 and one of our agents will administer your request. Or, if you’d prefer, fill out the form to submit an email.